Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: pathological implications in hypertension, renal and brain development, inflammation, and fibrosis

Pharmacol Res. 2021 Nov:173:105922. doi: 10.1016/j.phrs.2021.105922. Epub 2021 Oct 2.

Abstract

The (pro)renin receptor [(P)RR, Atp6ap2] was initially discovered as a membrane-bound binding partner of prorenin and renin. A soluble (P)RR has additional paracrine effects and is involved in metabolic syndrome and kidney damage. Meanwhile it is clear that most of the effects of the (P)RR are independent of prorenin. In the kidney, (P)RR plays an important role in renal dysfunction by activating proinflammatory and profibrotic molecules. In the brain, (P)RR is expressed in cardiovascular regulatory nuclei and is linked to hypertension. (P)RR is known to be an essential component of the v-ATPase as a key accessory protein and plays an important role in kidney, brain and heart via regulating the pH of the extracellular space and intracellular compartments. V-ATPase and (P)RR together act on WNT and mTOR signalling pathways, which are responsible for cellular homeostasis and autophagy. (P)RR through its role in v-ATPase assembly and function is also important for fast recycling endocytosis by megalin. In the kidney, megalin together with v-ATPase and (P)RR is crucial for endocytic uptake of components of the RAS and their intracellular processing. In the brain, (P)RR, v-ATPases and megalin are important regulators both during development and in the adult. All three proteins are associated with diseases such as XLMR, XMRE, X-linked parkinsonism and epilepsy, cognitive disorders with Parkinsonism, spasticity, intellectual disability, and Alzheimer's Disease which are characterized by impaired neuronal function and/or neuronal loss. The present review focusses on the relevant effects of Atp6ap2 without assigning them necessarily to the RAS. Mechanistically, many effects can be well explained by the role of Atp6ap2 for v-ATPase assembly and function. Furthermore, application of a soluble (P)RR analogue as new therapeutic option is discussed.

Keywords: (Pro)renin receptor; Autophagy; Endocytosis; Hypertension; Inflammation; Kidney and brain; Megalin; Renin-angiotensin-system; v-ATPase.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / growth & development
  • Brain / metabolism
  • Fibrosis
  • Humans
  • Hypertension / metabolism
  • Inflammation / metabolism
  • Kidney / growth & development
  • Kidney / metabolism
  • Kidney / pathology
  • Low Density Lipoprotein Receptor-Related Protein-2 / metabolism
  • Metabolic Syndrome / metabolism
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism*
  • Renin-Angiotensin System
  • TOR Serine-Threonine Kinases / metabolism
  • Vacuolar Proton-Translocating ATPases / genetics
  • Vacuolar Proton-Translocating ATPases / metabolism*
  • Wnt Signaling Pathway

Substances

  • ATP6AP2 protein, human
  • Low Density Lipoprotein Receptor-Related Protein-2
  • Receptors, Cell Surface
  • TOR Serine-Threonine Kinases
  • Vacuolar Proton-Translocating ATPases